EDDC and Hummingbird Bioscience enter into partnership to co-develop novel antibodies for cancer treatment
The Experimental Drug Development Centre (EDDC), Singapore’s national platform for drug discovery and development hosted at the Agency for Science, Technology and Research (A*STAR), and Hummingbird Bioscience, a clinical-stage biotech company, have entered a three-year partnership to develop novel antibodies for cancer immunotherapy. Immunotherapy can harness and enhance our body’s own immune defenses to fight […]